1-7 of 7
Salih Demir
Close
Sort by
Journal Articles

MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia

Elena Boldrin, Enrico Gaffo, Alexandra Niedermayer, Judith M. Boer, Martin Zimmermann, Dieter Weichenhan, Rainer Claus, Vera Münch, Qian Sun, Stefanie Enzenmüller, Felix Seyfried, Salih Demir, Julia Zinngrebe, Gunnar Cario, Martin Schrappe, Monique L. Den Boer, Christoph Plass, Klaus-Michael Debatin, Geertruij te Kronnie, Stefania Bortoluzzi, Lüder Hinrich Meyer
Journal: Blood
Blood (2021) 138 (20): 1953–1965.
https://doi.org/10.1182/blood.2020007591
Published: 2021
Includes: Supplemental data
Journal Articles

Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia

Fan Wang, Salih Demir, Franziska Gehringer, Clarissa D. Osswald, Felix Seyfried, Stefanie Enzenmüller, Sarah M. Eckhoff, Thomas Maier, Karlheinz Holzmann, Klaus-Michael Debatin, Thomas Wirth, Lüder H. Meyer, Alexey Ushmorov
Journal: Blood
Blood (2018) 131 (26): 2929–2942.
https://doi.org/10.1182/blood-2017-10-813576
Published: 2018
Includes: Supplemental data
Journal Articles

Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor

Vera Münch, Luca Trentin, Julia Herzig, Salih Demir, Felix Seyfried, Johann M. Kraus, Hans A. Kestler, Rolf Köhler, Thomas F. E. Barth, Geertruy te Kronnie, Klaus-Michael Debatin, Lüder H. Meyer
Journal: Blood
Blood (2017) 130 (5): 643–654.
https://doi.org/10.1182/blood-2017-03-769315
Published: 2017
Includes: Supplemental data
Journal Articles

FOXO1 Is Involved in the Regulation of B-Cell Precursor Acute Lymphoblastic Leukemia Survival and Serves As a Novel Target for Directed Therapy

Salih Demir, MSc, Fan Wang, Franziska Gehringer, Clarissa Weitzer, Klaus-Michael Debatin, MD PhD, Thomas Wirth, Prof. Dr., Lüder Hinrich Meyer, MD, Alexey Ushmorov, Dr.
Journal: Blood
Blood (2016) 128 (22): 4020.
https://doi.org/10.1182/blood.V128.22.4020.4020
Published: 2016
Journal Articles

Anti-Leukemia Activity of the Selective BCL-2 Inhibitor ABT-199 in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia Is Characterized By MCL-1/BCL-2 Expression Serving As Biomarker for Treatment Response

Felix Seyfried, MD, Salih Demir, MSc, Rebecca Hörl, Stefan Köhrer, Annika Scheffold, Stephan Stilgenbauer, Klaus-Michael Debatin, MD PhD, Lüder Hinrich Meyer, MD
Journal: Blood
Blood (2016) 128 (22): 1081.
https://doi.org/10.1182/blood.V128.22.1081.1081
Published: 2016
Journal Articles

Synergistic Activity of ABT-199 with Conventional Chemotherapy and Dinaciclib in B-Cell Precursor Acute Lymphoblastic Leukemia

Felix Seyfried, Salih Demir, MSc, Klaus-Michael Debatin, MDPhD, Lueder Hinrich Meyer, MD
Journal: Blood
Blood (2015) 126 (23): 2631.
https://doi.org/10.1182/blood.V126.23.2631.2631
Published: 2015
Journal Articles

Targeting Mutant p53 in Pediatric Acute Lymphoblastic Leukemia

Salih Demir, MSc, Galina Selivanova, PhD, Eugen Tausch, MD, Lisa Wiesmüller, PhD, Stephan Stilgenbauer, MDPhD, Geertruy Te Kronnie, PhD, Klaus-Michael Debatin, MDPhD, Lüder Hinrich Meyer, MD
Journal: Blood
Blood (2015) 126 (23): 903.
https://doi.org/10.1182/blood.V126.23.903.903
Published: 2015